sellWeak cluster of 2
Jamie Christensen sold $90k of MRTX
EVP & Chief Scientific Officer at Mirati Therapeutics, Inc.. 1,531 shares at an average of $58.81, traded Jan 4, 2024, filed Jan 5, 2024.
Warning score
32Value
$90k
1,531 shares
Holdings after
157,135
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +9Trade size$90k at market
- 0Share of holdings soldSold 1.0% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001628280-24-000699, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 4, 2024 | SOpen-market sale Common Stock | -1,531 | $58.81 | $90k | 157,135 | Jan 5, 2024 |
Related signals
Other insiders at Mirati Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | Mirati Therapeutics, Inc. | Jamie Christensen EVP & Chief Scientific Officer | $94k 1,597 shares | -1% | |
| 33Weak | Mirati Therapeutics, Inc. | Benjamin Hickey EVP, Chief Commercial Officer | $94k 1,597 shares | -1% | |
| 33Weak | Mirati Therapeutics, Inc. | Benjamin Hickey EVP, Chief Commercial Officer | $123k 2,090 shares | -2% | |
| 34Weak | Mirati Therapeutics, Inc. | Jamie Christensen EVP & Chief Scientific Officer | $137k 2,387 shares | -2% | |
| 34Weak | Mirati Therapeutics, Inc. | Benjamin Hickey EVP, Chief Commercial Officer | $126k 2,220 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.